Today: 16 May 2026

Zebra Medical Vision’s AI Reads Medical Images. Now Comes the Hospital Test

Zebra Medical Vision’s AI Reads Medical Images. Now Comes the Hospital Test

Nanox.AI, formerly Zebra Medical Vision, is now the imaging software unit of Nasdaq-listed Nanox, which acquired Zebra for $100 million in 2021. The company reported losses and financing risk in its 2026 filing but said it added Cedars-Sinai as a trial partner and accelerated U.S. deployment of its Nanox.ARC systems. NICE approved Nanox AI tools for NHS use during a three-year evidence period. FDA cleared its HealthFLD liver analysis software in 2024.
2 February 2024
·
AI Layoffs in 2023: The Real Number Was 4,247, and the Next Wave Is Harder to Count

AI Layoffs in 2023: The Real Number Was 4,247, and the Next Wave Is Harder to Count

U.S. employers cited artificial intelligence in 4,247 announced job cuts in 2023, according to Challenger, Gray & Christmas. By March 2026, AI was the top stated reason for U.S. job cuts that month, with 15,341 announced. The broader labor market showed 6.866 million job openings in March 2026, while layoffs remained at 1.2%, according to the Labor Department.
6 March 2023
···
1 … 1,940 1,941 1,942

Stock Market Today

  • TJX Companies Stock Pullback: Valuation Concerns Amid Market Decline
    May 15, 2026, 9:03 PM EDT. TJX Companies (TJX) shares fell 4.6% last week and 8.1% over the past month despite a 12.1% one-year and 135.2% five-year return. The retailer faces scrutiny as its valuation scores 0/6 on standard metrics, signaling no undervaluation. A Discounted Cash Flow (DCF) model estimates TJX's intrinsic value at $105.36 per share, contrasting with its $147 market price, suggesting a 39.9% premium and potential overvaluation. Investors are monitoring factors such as store traffic and consumer trends, impacting market sentiment. This combination of recent price weakness and valuation analysis raises questions regarding the stock's growth prospects and fair market value.

Latest articles

Dow Drops 537 Points With After-Hours Selling Threatening Wall Street AI Rally

Dow Drops 537 Points With After-Hours Selling Threatening Wall Street AI Rally

16 May 2026
U.S. stock ETFs fell in after-hours trading Friday following a more than 1% drop in the S&P 500, Dow, and Nasdaq. Oil surged 4.2% to $105.42 a barrel and the 10-year Treasury yield hit 4.597%, fueling concerns over inflation and Fed rate hikes. Nvidia, AMD, and Intel led chip declines, while Berkshire Hathaway disclosed a $2.65 billion Delta stake and exited Amazon, Visa, and Mastercard.
Accuray inks 10-year cancer tech agreement, shares in focus

Accuray inks 10-year cancer tech agreement, shares in focus

16 May 2026
Accuray and the University of Wisconsin School of Medicine and Public Health signed a 10-year research agreement focused on Accuray’s Stellar adaptive radiotherapy platform. The announcement came after market close, with Accuray shares ending down 5.2% at $0.27. The deal follows Accuray’s recent withdrawal of fiscal 2026 guidance and ongoing financial pressures.
Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

16 May 2026
Origin Materials asked shareholders to approve a plan to liquidate and dissolve the company, estimating an initial payout of $0.61 to $3.54 per share depending on asset sales and claims. Shares rose 15% to $1.43 after the filing. The company reported a 91% drop in first-quarter revenue and warned it may not survive without the wind-down. Origin cut 59% of its workforce and CEO John Bissell stepped down May 1.
NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

16 May 2026
NextNRG reported first-quarter revenue of $21.1 million, up 29% from a year earlier, but its net loss widened to $10.8 million. Cash fell to $208,048 at quarter-end, and management warned it needs immediate capital to continue operations. Shares closed at $0.2804 on Nasdaq, down nearly 6%. Total liabilities reached $34.3 million, with a stockholders’ deficit of $22 million.
Go toTop